Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
-
8/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

7 Years 5 Months

13 Years 8 Months

Fund AUM

₹89 Cr

₹9044 Cr

Min Investment
  1. SIP ₹200
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.96%

0.79%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

25

37

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(10.61%)
  2. Divi's Laboratories Ltd(7.56%)
  3. Apollo Hospitals Enterprise Ltd(6.63%)
  4. Torrent Pharmaceuticals Ltd(6.51%)
  5. Neuland Laboratories Ltd(5.49%)
  1. Sun Pharmaceuticals Industries Ltd(13.35%)
  2. Lupin Ltd(7.31%)
  3. Dr Reddy's Laboratories Ltd(6.72%)
  4. Cipla Ltd(6.16%)
  5. Divi's Laboratories Ltd(5.8%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(91.82%)
  2. Basic Materials(8.18%)

Health

(100%)

Equity %

92.92%

97.92%

Debt %

-

-

P/E

46.25

38.2

P/B

6.08

5.65

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

5.11%

4.25%

3-Month Return

17.12%

13.16%

6-Month Return

12.76%

10.95%

1-Year Return

12.71%

9.76%

3-Year Return

23.22%

21.44%

5-Year Return

12.24%

13.55%

Sharpe

0.98

0.97

Alpha

-0.49

-0.78

Beta

0.93

0.89

Standard Deviation

16.06

15.23

Information Ratio

-0.46

-0.76

Description

LIC MF Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Sudhanshu Asthana

Sailesh Raj Bhan, Kinjal Desai, Amber Singhania

Most Popular Comparisons